Here are relevant reports on : metagenomic-sequencing-market

• Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial) - Global Forecast to 2028

  The global metagenomic sequencing market, valued at US$1.8 billion in 2022, stood at US$2.0 billion in 2023 and is projected to advance at a resilient CAGR of 17.5% from 2023 to 2028, culminating in a forecasted valuation of US$4.5billion by the end of the period. NGS platforms have undergone continuous technological innovations over the last several years.

  • Published: July 2023
  • Price: $ 4950
  • TOC Available:

• Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Global Forecast to 2028

  The global microbiome sequencing services market, valued at US$250 million in 2022, stood at US$284 million in 2023 and is projected to advance at a resilient CAGR of 14.3% from 2023 to 2028, culminating in a forecasted valuation of US$555 billion by the end of the period. Growth in this market is primarily driven by the increasing demand for metagenomic sequencing, the growing focus on the development of human microbiome therapeutics, and the high cost of advanced sequencing infrastructure.

  • Published: May 2023
  • Price: $ 4950
  • TOC Available:

• miRNA Sequencing and Assay Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region - Global Forecast To 2024

  The miRNA sequencing and assays market is projected to reach USD 343 million by 2024, at a CAGR of 11.2%. Growth in this market is driven by factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing.Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), NEB (UK), and 5 others.

  • Published: March 2019
  • Price: $ 4950
  • TOC Available:

• Whole Exome Sequencing Market by Product [Systems, Kits (Library Preparation, Target Enrichment)], Services (Sequencing), Technology (Sequencing by Synthesis), & by Application (Cancer, Monogenic disorders) - Global Forecast to 2018

  This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership in the market in the coming years. Growth in the North American market is likely to be driven by factors such as the increasing use of exome sequencing in rare disease research, increased government funding, and large number of sequencing-related conferences and annual meetings hosted by the U.S.

  • Published: August 2014
  • Price: $ 4950
  • TOC Available:

• Long Read Sequencing Market by Offerings (Consumables, Instruments, Services), Workflow (Sample Prep, Sequencing, Data Analysis), Technology (Nanopore, SMRT), Application (WGS, WES, Epigenetics), Usage (Clinical, Research) - Global Forecast to 2029

  The global long-read sequencing market, valued at US$596 million in 2023, stood at US$758 million in 2024 and is projected to advance at a resilient CAGR of 32.8% from 2024 to 2029, culminating in a forecasted valuation of US$3,129 million by the end of the period. The main forces behind the growth of this market are the rising frequency of complex genetic disorders, expanding applications of long-read sequencing, and the technological development in genome sequencing aiding in the adoption of third-generation sequencing.

  • Published: August 2024
  • Price: $ 4950
  • TOC Available:

• Immune Repertoire Sequencing Market by Product (Instrument, Software, Assay Kit & Reagent (TCR, BCR Kit)), Technology (Sequencing, Bioinformatics), Service (Data Analysis), Application (Research, Drug Discovery & Development) - Global Forecast to 2030

  Global immune repertoire sequencing market valued at $344.2M in 2024, reached $354.6M in 2025, and is projected to grow at a robust 9.6% CAGR, hitting $560.5M by 2030. The growth of the Asia Pacific IRS market is primarily due to growing R&D investments and the increasing presence of major industry stakeholders in the region.

  • Published: April 2025
  • Price: $ 4950
  • TOC Available:

• Single Cell Sequencing Market by Product (Reagents & Kits, Platforms, Software), Workflow (Presequencing), Service (Sample Preparation, Bioinformatics), Sequencing (scRNA, scDNA), Application (Research, Diagnostic), End User - Global Forecast to 2030

  The global Single Cell Sequencing market, valued at US$1.89 billion in 2024, stood at US$1.95 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$3.46 billion by the end of the period. This growth is driven by advancements in single-cell workflow, including more efficient cell isolation methods, improved library preparation kits, and high-throughput, cost-effective sequencing platforms.

  • Published: July 2025
  • Price: $ 4950
  • TOC Available:

• North America Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture)-Forecast to 2030

  The North America next-generation sequencing market is expected to grow from USD 6.15 billion in 2025 to USD 11.63 billion by 2030, at a compound annual growth rate (CAGR) of 13.6% during the forecast period. The key Players Illumina (US), Thermo Fisher Scientific (US), Roche (Switzerland), and Danaher (US).

  • Published: February 2026
  • Price: $ 4950
  • TOC Available:

• Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029

  The global next-generation sequencing market, valued at US$12.13 billion in 2023, stood at US$12.65 billion in 2024 and is projected to advance at a resilient CAGR of 13.2% from 2024 to 2029, culminating in a forecasted valuation of US$23.55 billion by the end of the period. The primary growth drivers of the next-generation sequencing market are the surge in the rising demand for precision medicine in identifying genetic mutations and biomarkers, enabling targeted therapies and advancing precision medicine initiatives globally.

  • Published: January 2025
  • Price: $ 4950
  • TOC Available:

• DNA Sequencing Market - Global Forecast to 2030

  The DNA sequencing market has experienced significant growth and transformation in recent years, driven by advancements in sequencing technologies, decreasing costs, and expanding applications. Here is an overview of the market outlook for DNA sequencing:

  • Published: January 2026
  • Price: $ 4950
  • TOC Available:

• NEXT
• LAST

Records 1 to 10 of 50